# The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

> **NCT01971346** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 50 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** etanercept

## Key facts

- **NCT ID:** NCT01971346
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-13
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01971346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01971346, "The Immunological Basis for Treatment Resistance to Anti-TNF Treatments". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01971346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*